QTLs in Region (GRCm39)
1302162 | Ednrbm1_m | endothelin receptor type B modifier 1 (mouse) | | | Not determined | | 10 | 92127383 | 103713756 | Mouse |
1301520 | Uvbi1_m | UVB induced immunosuppression 1 (mouse) | | | Not determined | | 10 | 86909085 | 120909229 | Mouse |
4142137 | Femwf3_m | femur work to failure 3 (mouse) | | | Not determined | | | 75338568 | 109338767 | Mouse |
27226772 | Tibl13_m | tibia length 13, 10 week (mouse) | | | | | 10 | 18875748 | 129635869 | Mouse |
4142386 | Tgq20_m | triglyceride QTL 20 (mouse) | | | Not determined | | | 88836456 | 122836456 | Mouse |
1357594 | Estoq3_m | embryo survival total QTL 3 (mouse) | | | Not determined | | 10 | 84079650 | 122041528 | Mouse |
27226764 | Tibl19_m | tibia length 19, 16 week (mouse) | | | | | 10 | 39175996 | 129635869 | Mouse |
1357831 | Igf1sl2_m | IGF-1 serum levels 2 (mouse) | | | Not determined | | 10 | 87694127 | 99936278 | Mouse |
15092081 | Igly8_m | IgG glycosylation 10, GP25 (mouse) | | | | | 10 | 92861526 | 93927618 | Mouse |
4141479 | W10q8_m | weight 10 weeks QTL 8 (mouse) | | | Not determined | | | 84079650 | 122041528 | Mouse |
14747004 | Mancz8_m | mandible centroid size 8 (mouse) | | | | | 10 | 82078412 | 116078412 | Mouse |
4142496 | W6q8_m | weight 6 weeks QTL 8 (mouse) | | | Not determined | | | 84079650 | 122041528 | Mouse |
1302067 | Scc9_m | colon tumor susceptibility 9 (mouse) | | | Not determined | | 10 | 18259333 | 125575232 | Mouse |
12910821 | Ogrq4_m | overall growth rate QTL 4 (mouse) | | | | | 10 | 92169056 | 107319989 | Mouse |
26884411 | Bzwq8_m | bi-zygomatic width QTL 8, 10 week (mouse) | | | | | 10 | 44876096 | 115935905 | Mouse |
11039497 | Ltpr5a_m | Leishmania tropica response 5a (mouse) | | | | | 10 | 73506901 | 107507047 | Mouse |
1357622 | Espq3_m | embryo survival preimplantation QTL 3 (mouse) | | | Not determined | | 10 | 84079650 | 122041528 | Mouse |
4142365 | Egq9_m | early growth QTL 9 (mouse) | | | Not determined | | | 84079650 | 122041528 | Mouse |
13208554 | Lgth11_m | body length 11 (mouse) | | | | | 10 | 90835862 | 120835905 | Mouse |
1300533 | Aem3_m | anti-erythrocyte autoantibody modifier 3 (mouse) | | | Not determined | | 10 | 65490938 | 99491121 | Mouse |
1300921 | Skl4_m | skeletal size (tail length) 4 (mouse) | | | Not determined | | 10 | 88088254 | 122088391 | Mouse |
26884407 | Bzwq14_m | bi-zygomatic width QTL 14, 16 wee (mouse) | | | | | 10 | 45476096 | 120635905 | Mouse |
11251717 | Siim1_m | stress induced immobility 1 (mouse) | | | | | 10 | 78381268 | 112381268 | Mouse |
1300797 | Sluc22_m | susceptibility to lung cancer 22 (mouse) | | | Not determined | | 10 | 86713608 | 120713756 | Mouse |
26884405 | Huml2_m | humerus length 2, 5 week (mouse) | | | | | 10 | 69735830 | 130430862 | Mouse |
11039516 | Ltpr5_m | Leishmania tropica response 5 (mouse) | | | | | 10 | 90506901 | 125575232 | Mouse |
1357740 | Obsty3_m | obesity 3 (mouse) | | | Not determined | | 10 | 8235478 | 116190980 | Mouse |
13208560 | Wght9_m | weight 9 (mouse) | | | | | 10 | 59835822 | 120835905 | Mouse |
1301165 | Lith7_m | lithogenic gene 7 (mouse) | | | Not determined | | 10 | 82309418 | 116309657 | Mouse |
1302060 | El3_m | epilepsy 3 (mouse) | | | Not determined | | 10 | 65490938 | 99491121 | Mouse |
1300908 | Insq4_m | insulin QTL 4 (mouse) | | | Not determined | | 10 | 86909085 | 120909229 | Mouse |
4141054 | mwfh_m | modifier of white forlock hypopigmentation (mouse) | | | Not determined | | | 83017003 | 117017136 | Mouse |
26884447 | Sklq9_m | skull length QTL 9, 10 week (mouse) | | | | | 10 | 67335830 | 111735905 | Mouse |
11353832 | Pcholq4_m | plasma cholesterol QTL 4 (mouse) | | | | | 10 | 73987216 | 125515907 | Mouse |
4142074 | Tmevp2_m | Theiler's murine encephalomyelitis virus persistence 2 (mouse) | | | Not determined | | | 92729941 | 111568319 | Mouse |
1357779 | Tesq3_m | testis weight QTL 3 (mouse) | | | Not determined | | 10 | 84079650 | 122041528 | Mouse |
11059553 | Lmr32d_m | leishmaniasis resistance 32d (mouse) | | | | | 10 | 82309418 | 116309657 | Mouse |
11059554 | Lmr32e_m | leishmaniasis resistance 32e (mouse) | | | | | 10 | 82309418 | 116309657 | Mouse |
11059555 | Lmr32f_m | leishmaniasis resistance 32f (mouse) | | | | | 10 | 82309418 | 116309657 | Mouse |
26884426 | Cvht1_m | cranial vault height 1, 5 week (mouse) | | | | | 10 | 24675898 | 121035905 | Mouse |
26884424 | Zlq9_m | zygomatic length QTL 9, 16 week (mouse) | | | | | 10 | 63935779 | 115935905 | Mouse |
1357638 | Cia29_m | collagen induced arthritis 29 (mouse) | | | Not determined | | 10 | 85454982 | 118497353 | Mouse |
26884430 | Zlq5_m | zygomatic length QTL 5, 10 week (mouse) | | | | | 10 | 67835830 | 124835905 | Mouse |
1357632 | Vtbt9_m | vertebral trabecular bone trait 9 (mouse) | | | Not determined | | 10 | 75338568 | 109338767 | Mouse |
11353843 | Gluq1_m | blood glucose QTL 1 (mouse) | | | | | 10 | 73987216 | 125515907 | Mouse |
1301758 | Fcsa3_m | femoral cross-sectional area 3 (mouse) | | | Not determined | | 10 | 89927651 | 123927754 | Mouse |
10043881 | Adip24_m | adiposity 24 (mouse) | | | Not determined | | 10 | 82392803 | 116392952 | Mouse |
1558757 | Eae34_m | experimental allergic encephalomyelitis susceptibility 34 (mouse) | | | Not determined | | 10 | 21408154 | 114217230 | Mouse |
4141387 | Lgaq5_m | late growth adjusted QTL 5 (mouse) | | | Not determined | | | 84079650 | 122041528 | Mouse |
11059550 | Lmr32a_m | leishmaniasis resistance 32a (mouse) | | | | | 10 | 82309418 | 116309657 | Mouse |
11059551 | Lmr32b_m | leishmaniasis resistance 32b (mouse) | | | | | 10 | 82309418 | 116309657 | Mouse |
26884450 | Sklq15_m | skull length QTL 15, 16 week (mouse) | | | | | 10 | 59335822 | 122335905 | Mouse |
27095911 | Pglq15_m | pelvic girdle length QTL 15, 16 week (mouse) | | | | | 10 | 39175996 | 129635869 | Mouse |
1301737 | Insq9_m | insulin QTL 9 (mouse) | | | Not determined | | 10 | 65490938 | 99491121 | Mouse |
1300975 | Fembrs3_m | femur breaking strength 3 (mouse) | | | Not determined | | 10 | 75338568 | 109338767 | Mouse |